Helicobacter Pylori Testing Market Outlook (2022 to 2032)

The global helicobacter pylori testing market is expected to accumulate USD 173.1 Million in value by 2022-end. During the forecast period ranging from 2022 to 2032, a CAGR worth 7.4% has been projected for the market, with an expected closing value worth USD 380.3 Million. During the 2016 to 2021 historical period, the industry grew at a value CAGR worth 6.2%.

Growing awareness of immunodiagnostics in developed countries like the United States & Germany and increasing product approvals boost the demand for Helicobacter Pylori Testing.

Attributes Key Statistics
Global Helicobacter Pylori Testing Market CAGR (2022 to 2032) 7.4%
Anticipated Market Value (2022) USD 173.1 Million
Global Helicobacter Pylori Testing Market (2032) USD 380.3 Million
Global Helicobacter Pylori Testing Market Attraction People's growing awareness of immunodiagnostics, rapid advances in technology and innovation, and increasing product approvals are anticipated to propel the global helicobacter pylori testing market forward.

Helicobacter pylori testing is used to diagnose Helicobacter pylori infections in the upper small intestine and stomach. The helicobacter pylori test is also used to evaluate treatment efficacy. Peptic ulcers, stomach (gastric) cancer, and chronic gastritis can all be caused by helicobacter pylori.

Helicobacter pylori testing is used to determine whether a helicobacter pylori infection is causing an ulcer. There are various types of helicobacter pylori testing obtainable. Some of them require a stool or breath sample, while others are more invasive and require a tissue sample obtained via endoscopy.

The bacteria Helicobacter pylori grow in the digestive tract and have a proclivity to attack the stomach lining. Helicobacter pylori infections are usually harmless, but they are responsible for the vast majority of small intestine and stomach ulcers. Because it is the most common illness in humans, early detection is critical. According to CDC research, Helicobacter pylori causes more than 90% of duodenal ulcers and up to 80% of gastric ulcers.

Exclusive Offer: 30% Off on Regional Reports

Get a free sample report and customize your regions for a 30% discount on your regional report!

What are the Factors Propelling the Global Helicobacter Pylori Testing Market?

The global helicobacter pylori testing industry is poised to increase consistently over the forecast period due to an aging population and an increase in the prevalence of infectious diseases and gastritis. People's growing awareness of immunodiagnostics, rapid advances in technology and innovation, and increasing product approvals are anticipated to propel the global helicobacter pylori testing market forward.

The advancement of newer innovations to enhance accuracy and precision has stemmed from a preference for non-invasive testing. Furthermore, non-invasive tests allow for multiple sample screenings at the same time, which a ects its acceptance rate. Reduced time, reduction of other infections during invasive testing, and less severe pain will all encourage more people to use non-invasive testing.

What are the Factors Hampering the Global Helicobacter Pylori Testing Market?

However, high test costs and a lack of awareness about helicobacter pylori testing are major factors restricting the growth of the global helicobacter pylori testing market.

Underdeveloped and developing countries face challenges related to a lack of healthcare resources. This results in limited access to healthcare services with insufficient facilities, which increases the likelihood of a lack of knowledge about such diseases and their diagnosis.

Get Brochure on Email

Almost 80% of our clients request uniquely tailored intelligence.

Why is North America Emerging as an Opportunistic Helicobacter Pylori Testing Market?

The market for Helicobacter pylori testing in North America is expected to take a turn for the better, attributed to the growing prevalence of H. pylori infections, rising awareness about disease diagnosis and treatment, and government initiatives to eradicate the incidence of infections.

The bacteria pose a high risk of stomach cancer, contributing to the existing disease burden, and are thus bound to grow the associated incidence and mortality among African Americans in the United States. Furthermore, advances in diagnostic technology and the inclusion of advanced healthcare infrastructure will fuel the country's growth. According to Future Market Insights, North America is likely to account for a 36.4% market share as of 2022.

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately half of the people over the age of 60 and 20% of people under the age of 40 are infected with Helicobacter Pylori in the United States. Furthermore, technological advancements in Helicobacter pylori diagnostics, as well as the presence of a well-established healthcare infrastructure, are fuelling the market's growth to a large extent.

Why is the Demand for Helicobacter Pylori Testing Burgeoning in Europe?

Europe is thought to have the second-largest H. pylori testing market share, accumulating 32% revenue as of 2022. An important factor is the widespread utilization of antibiotics in many countries. In addition, rising investments and the presence of various key players are being evaluated to drive market growth.

The European market for helicobacter pylori testing is expected to be the second largest. The increasing patient pool intent on early detection of helicobacter pylori infection to avoid peptic ulcers is expected to aid market growth in the European region.

The role of H pylori in gastritis, peptic ulcers, and gastric cancer is now established, but research currently underway into possible associations with cardiovascular disease and several other conditions could guarantee a massive market in Europe for H pylori diagnostic tests and antimicrobial eradication therapy.

According to the National Institute for Health Research, the ubiquity of Helicobacter pylori is intense in most countries, including North European populations, where approximately one-third of adults are still infected, whereas, in South America, Asia, and south and east Europe, the prevalence is greater than 50%. Furthermore, Helicobacter pylori remain highly prevalent in immigrants from Helicobacter pylori-endemic countries in Europe. These factors are anticipated to propel the global helicobacter pylori testing market forward in Europe.

Check Free Sample Report & Save 40%!

Select your niche segments and personalize your insights for smart savings. Cut costs now!

How Start-ups are Adding Value to the Global Helicobacter Pylori Testing Market

The swelling dispersion of start-ups in the Helicobacter Pylori Testing market has improved product quality and expanded global sales. Besides, to gain a competitive edge, new start-ups are working on innovative developments and launching new products such as:

  • In 2010, Sekisui Diagnostics (UK) Ltd was established. The company's product line includes medical, surgical, ophthalmic, and veterinary instruments and apparatus. OSOM® H. pylori Test For the qualitative detection of H. pylori antibodies in serum, plasma, or whole blood as an aid in the diagnosis of H. pylori infection was recently launched by the company.

Who are the Key Players in the Global Helicobacter Pylori Testing Packaging Market?

Some key players in the Helicobacter Pylori Testing packaging market are Abbott, ADI/American Diagnostica, Agilent Technologies, Bio-Rad Laboratories, Inc., Helena Laboratories, Horiba, Takara Bio, EKF Diagnostics, Exalenz Bioscience Ltd. and Sekisui Diagnostics, LLC. A key development in the Helicobacter Pylori Testing Packaging market is as follows:

  • Horiba launched the Horiba ABX Micros ESV 60 Hematology Analyzer in November 2021, which is the Gold Standard of Veterinary Hematology Testing for 11 animal species.

In July 2022, Bio-Rad released Platelia H. pylori IgG, an immuno-enzymatic assay for the qualitative determination of IgG antibodies. Serology provides a non-invasive, sensitive, and simple method for determining H. pylori infection. Platelia H. pylori IgG is an immunoenzymatic assay for determining the quality of IgG antibodies.

Report Scope

Report Attribute Details
Growth Rate CAGR of 7.4% from 2022 to 2032
Market Value in 2022 USD 173.1 Million
Market Value in 2032 USD 380.3 Million
Base Year for Estimation 2021
Historical Period 2016 to 2021
Forecast Period 2022 to 2032
Quantitative Units Revenue in USD Million and CAGR from 2022 to 2032
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered Test Type, End Use, Region
Regions Covered North America; Latin America; Europe; Asia Pacific; Middle East and Africa
Key Countries Profiled United States of America, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC Countries, South Africa, Israel
Key Companies Profiled Abbott Laboratories; ADI/American Diagnostica; Agilent Technologies; Bio-Rad Laboratories, Inc.; Helena Laboratories; Horiba; Takara Bio; EKF Diagnostics; Exalenz Bioscience Ltd.; Sekisui Diagnostics, LLC
Customization Available Upon Request
Table of Content
  • 1. Executive Summary
  • 2. Market Overview
  • 3. Market Background
  • 4. Global Market Analysis 2016 to 2021 and Forecast, 2022 to 2032
  • 5. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Test Type
    • 5.1. With Endoscopy
    • 5.2. Histology
    • 5.3. Rapid Urease Testing
    • 5.4. Culture
    • 5.5. PCR (Polymerase Chain Reaction)
    • 5.6. Without Endoscopy
    • 5.7. Stool/Faecal Antigen Test
    • 5.8. Urea Breath Test
    • 5.9. H. Pylori Antibody Testing
  • 6. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User
    • 6.1. Hospitals
    • 6.2. Private Labs
    • 6.3. Public Health Labs
    • 6.4. Physician Offices
  • 7. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region
    • 7.1. North America
    • 7.2. Latin America
    • 7.3. Europe
    • 7.4. Asia Pacific
    • 7.5. Middle East and Africa
  • 8. North America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
  • 9. Latin America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
  • 10. Europe Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
  • 11. Asia Pacific Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
  • 12. Middle East and Africa Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
  • 13. Key Countries Market Analysis
  • 14. Market Structure Analysis
  • 15. Competition Analysis
    • 15.1. Abbott
    • 15.2. ADI/American Diagnostica
    • 15.3. Agilent Technologies
    • 15.4. Bio-Rad Laboratories Inc.
    • 15.5. Helena Laboratories
    • 15.6. Horiba
    • 15.7. Takara Bio
    • 15.8. EKF Diagnostics
    • 15.9. Exalenz Bioscience Ltd.
    • 15.10. Sekisui Diagnostics
  • 16. Assumptions & Acronyms Used
  • 17. Research Methodology

Key Segments Covered in the Helicobacter Pylori Testing Industry Survey

Helicobacter Pylori Testing Market by Test Type:

  • Helicobacter Pylori Testing with Endoscopy
    • Histology
    • Rapid Urease Testing
    • PCR (Polymerase Chain Reaction)
    • Culture Testing
  • Helicobacter Pylori Testing without Endoscopy
    • Stool/Faecal Antigen Test
    • Urea Breath Test
    • H. Pylori Antibody Testing

Helicobacter Pylori Testing Market by End User:

  • Helicobacter Pylori Testing in Hospitals
  • Helicobacter Pylori Testing in Private Labs
  • Helicobacter Pylori Testing in Public Health Labs
  • Helicobacter Pylori Testing in Physician Offices

Helicobacter Pylori Testing Market by Region:

  • North America Helicobacter Pylori Testing Market
  • Latin America Helicobacter Pylori Testing Market
  • Europe Helicobacter Pylori Testing Market
  • Asia Pacific Helicobacter Pylori Testing Market
  • Middle East & Africa Helicobacter Pylori Testing Market

Frequently Asked Questions

What is the estimated market value of the helicobacter pylori testing market in 2022?

The global helicobacter pylori testing market is likely to value at USD 173.1 Million in 2022.

What is the projected CAGR of the helicobacter pylori testing market until 2032?

The helicobacter pylori testing market is estimated to grow at a CAGR of 7.4% from 2022 to 2032.

What is the expected market value of the global helicobacter pylori testing market by 2032?

The helicobacter pylori testing market is predicted to procure USD 380.3 Million by 2032.

Recommendations

Antibacterial Haemostatic Gels Market
Expected Market Value in 2023 USD 1.4 Billion
Projected Market Value in 2033 USD 2.6 Billion
Growth Rate (2023 to 2033) CAGR of 6.4%
Urinary Antibacterial And Antiseptic Pharmaceuticals Market
Market Value (2022) USD 44.2 Billion
Market Value (2032) USD 67.34 Billion
Market CAGR (2022 to 2032) 4.3%
Microbial Identification Market
Estimated Market Value (2022) USD 3.7 Billion
Projected Market Value (2032) USD 10.7 Billion
Value-based CAGR (2022 to 2032) 11.3%

Explore In-vitro Diagnostics Devices Insights

View Reports
Trusted By
Future Market Insights

Helicobacter Pylori Testing Market

Schedule a Call